PMID: 8923569Oct 1, 1996

Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol

M F EganT M Hyde


Late onset vacuous chewing movements (VCMs) from chronic neuroleptic treatment have been used as a rat model of tardive dyskinesia (TD). Early onset VCMs have also been observed, raising questions about the validity of this model. To assess the relationship between these two types of VCMs, pharmacological and neurochemical properties of early and late onset VCMs were compared. "Acute" VCMs were induced by daily intraperitoneal injections for 1-21 days. "Tardive" VCMs were induced by intramuscular injections of haloperidol decanoate every 3 weeks for 30 weeks followed by a 24-week withdrawal period. Suppression was attempted for both types of VCMs using several doses of intraperitoneal haloperidol. Striatonigral activation was assessed by measuring mRNA expression levels of the neuropeptides dynorphin and substance P using in situ hybridization histochemistry. Enkephalin mRNA was also measured as an index of striatopallidal activation. The results indicate that acute VCMs cannot be suppressed with increased doses of haloperidol and are associated with reduced dynorphin and substance P. This profile is similar to that seen with an animal model of parkinsonism. Tardive VCMs, in contrast, were markedly suppressed by haloperidol. Th...Continue Reading


Mar 7, 2006·Psychopharmacology·Spiridon KonitsiotisAngelos Evangelou
Oct 7, 2006·Journal of Neural Transmission·T Archer, R J Beninger
Nov 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Helen Rosengarten, David Quartermain
Jan 13, 2000·Progress in Neuro-psychopharmacology & Biological Psychiatry·Helen RosengartenA J Friedhoff
Jan 1, 1999·Progress in Neurobiology·John D SalamoneA Nawab
Dec 13, 2000·Neuroscience·J M Van Kampen, A J Stoessl
May 3, 2003·Brain Research Bulletin·R C CarvalhoR Frussa-Filho
Mar 14, 2007·Behavioural Pharmacology·Darakhshan Jabeen HaleemMuhammad Abdul Haleem
Mar 13, 2012·Behavioral and Brain Functions : BBF·Pierre J BlanchetDaniel Lévesque
Apr 26, 2013·Experimental Brain Research·Philippe De DeurwaerdèreS Navailles
Jul 14, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Meaghan CreedJosé N Nobrega
Jul 16, 2009·Pharmacology, Biochemistry, and Behavior·J TrevittC Larsen
Dec 1, 2015·Pharmacology & Therapeutics·Giuseppe Di Giovanni, Philippe De Deurwaerdère
May 15, 2007·Pharmacology, Biochemistry, and Behavior·Darakhshan Jabeen HaleemMuhammad Abdul Haleem
Feb 12, 2005·Biological Psychiatry·Peter TurroneJosé N Nobrega
Apr 22, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jivago RopkeRoselei Fachinetto
Aug 28, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Joshua ListerGary Remington
Oct 19, 2016·Neurochemical Research·Tafheem MalikDarakhshan Jabeen Haleem
May 11, 2006·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·William R Marchand, Valentina Dilda
Dec 7, 2013·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Pedro H GobiraFabrício A Moreira
Jan 14, 2017·Frontiers in Psychiatry·Ryoma MorigakiSatoshi Goto
Jul 3, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Peter TurroneJosé N Nobrega
Sep 14, 2013·The Journal of Pharmacology and Experimental Therapeutics·Roger D PorsoltDavid Virley
Feb 19, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Pierre J Blanchet, Daniel Lévesque
Jun 20, 2019·Current Protocols in Neuroscience·Fausto Pierdoná GuzenDayane Pessoa de Araújo

Related Concepts

Behavior, Animal
Lentiform Nucleus Structure
Dynorphin (1-17)
Dyskinesia, Medication-Induced
Nucleus Accumbens
Poly(A) Tail
Hypothalamic Substance P

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here